TY - JOUR
T1 - West nile and usutu virus infections and challenges to blood safety in the European Union
AU - Domanović, Dragoslav
AU - Gossner, Celine M.
AU - Lieshout-Krikke, Ryanne
AU - Mayr, Wolfgang
AU - Baroti-Toth, Klara
AU - Dobrota, Alina Mirella
AU - Escoval, Maria Antonia
AU - Henseler, Olaf
AU - Jungbauer, Christof
AU - Liumbruno, Giancarlo
AU - Oyonarte, Salvador
AU - Politis, Constantina
AU - Sandid, Imad
AU - Vidović, Miljana Stojić
AU - Young, Johanna J.
AU - Ushiro-Lumb, Inês
AU - Nowotny, Norbert
N1 - Publisher Copyright:
© 2019, Centers for Disease Control and Prevention (CDC). All rights reserved.
PY - 2019/6
Y1 - 2019/6
N2 - West Nile virus (WNV) and Usutu virus (USUV) circulate in several European Union (EU) countries. The risk of transfusion- transmitted West Nile virus (TT-WNV) has been recognized, and preventive blood safety measures have been implemented. We summarized the applied interventions in the EU countries and assessed the safety of the blood supply by compiling data on WNV positivity among blood donors and on reported TT-WNV cases. The paucity of reported TTWNV infections and the screening results suggest that blood safety interventions are effective. However, limited circulation of WNV in the EU and presumed underrecognition or underreporting of TT-WNV cases contribute to the present situation. Because of cross-reactivity between genetically related flaviviruses in the automated nucleic acid test systems, USUV-positive blood donations are found during routine WNV screening. The clinical relevance of USUV infection in humans and the risk of USUV to blood safety are unknown.
AB - West Nile virus (WNV) and Usutu virus (USUV) circulate in several European Union (EU) countries. The risk of transfusion- transmitted West Nile virus (TT-WNV) has been recognized, and preventive blood safety measures have been implemented. We summarized the applied interventions in the EU countries and assessed the safety of the blood supply by compiling data on WNV positivity among blood donors and on reported TT-WNV cases. The paucity of reported TTWNV infections and the screening results suggest that blood safety interventions are effective. However, limited circulation of WNV in the EU and presumed underrecognition or underreporting of TT-WNV cases contribute to the present situation. Because of cross-reactivity between genetically related flaviviruses in the automated nucleic acid test systems, USUV-positive blood donations are found during routine WNV screening. The clinical relevance of USUV infection in humans and the risk of USUV to blood safety are unknown.
UR - http://www.scopus.com/inward/record.url?scp=85066937071&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066937071&partnerID=8YFLogxK
U2 - 10.3201/eid2506.181755
DO - 10.3201/eid2506.181755
M3 - Article
C2 - 31107223
AN - SCOPUS:85066937071
SN - 1080-6040
VL - 25
SP - 1050
EP - 1057
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 6
ER -